Growth Metrics

Eastman Chemical (EMN) Gains from Investment Securities (2016 - 2026)

Eastman Chemical (EMN) has disclosed Gains from Investment Securities for 18 consecutive years, with $4.0 million as the latest value for Q1 2026.

  • For Q1 2026, Gains from Investment Securities rose 180.0% year-over-year to $4.0 million; the TTM value through Mar 2026 reached -$16.0 million, up 5.88%, while the annual FY2025 figure was -$25.0 million, 38.89% down from the prior year.
  • Gains from Investment Securities hit $4.0 million in Q1 2026 for Eastman Chemical, up from -$20.0 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $19.0 million in Q1 2023 and bottomed at -$30.0 million in Q3 2023.
  • Average Gains from Investment Securities over 5 years is -$4.4 million, with a median of -$5.5 million recorded in 2022.
  • On a YoY basis, Gains from Investment Securities climbed as much as 1200.0% in 2022 and fell as far as 850.0% in 2022.
  • Eastman Chemical's Gains from Investment Securities stood at $13.0 million in 2022, then crashed by 161.54% to -$8.0 million in 2023, then tumbled by 125.0% to -$18.0 million in 2024, then fell by 11.11% to -$20.0 million in 2025, then soared by 120.0% to $4.0 million in 2026.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $4.0 million, -$20.0 million, and -$5.0 million for Q1 2026, Q4 2025, and Q1 2025 respectively.